Imagen de Portada

Editorial: Disorders of gut‐brain interaction—Don't forget the older person

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autor principal:	Christopher J. Black
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Alimentary Pharmacology & Therapeutics
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Editorial: Variceal Bleeding in Patients Receiving Atezolizumab–Bevacizumab for Hepatocellular Carcinoma—Don't Ignore the Risk Factors! Authors' Reply
por: Jonggi Choi
Publicado: (2025)

Review article: The role of the gut–brain axis in inflammatory bowel disease and its therapeutic implications
por: Christy Riggott, et al.
Publicado: (2024)

Editorial: Disordered eating and irritable bowel syndrome—Do maladaptive eating and weight control behaviours increase risk of a maladaptive gut?
por: Andrea Shin
Publicado: (2024)

Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability?
por: Joshua Reid, et al.
Publicado: (2024)

Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability? Authors' reply
por: Jessica A. Fitzpatrick, et al.
Publicado: (2024)

Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care
por: Vivek C. Goodoory, et al.
Publicado: (2024)

Stability of Classification Systems for Irritable Bowel Syndrome
por: Mais Khasawneh, et al.
Publicado: (2025)

Meta‐Analysis: Prevalence of Eating Disorders in Inflammatory Bowel Disease
por: Quinn Goddard, et al.
Publicado: (2025)

Editorial: When and What to Ask—Capturing the Symptoms Experienced by Patients With PSC. Authors' Reply
por: Natassia Tan, et al.
Publicado: (2025)

Persistence of Symptoms of Anxiety and Depression in Inflammatory Bowel Disease: A Longitudinal Follow‐Up Study
por: Christy Riggott, et al.
Publicado: (2025)

Prevalence of Opioid Use and Associated Healthcare Outcomes in Rome IV Irritable Bowel Syndrome in the United Kingdom
por: Mohsin F. Butt, et al.
Publicado: (2025)

Editorial: When and What to Ask—Capturing the Symptoms Experienced by Patients With PSC
por: Christopher L. Bowlus, et al.
Publicado: (2025)

Disordered Bile Acid Metabolism in Alcohol‐Related Hepatitis
por: Luke D. Tyson, et al.
Publicado: (2026)

Letter (brief communication): A pilot study of hemp hull bio gut fibre (BGF) to reduce intestinal permeability in IBS‐BAD
por: Camille Lupianez‐Merly, et al.
Publicado: (2024)

Editorial: High‐Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer
por: Alexandra Hickey, et al.
Publicado: (2025)

Editorial: Defining corticosteroid use in clinical trials
por: J. Siffledeen
Publicado: (2024)

Editorial: Cephalosporin‐Induced Liver Injury—Interesting but Tricky. Authors' Reply
por: Raj Vuppalanchi, et al.
Publicado: (2025)

Letter: Diet‐microbiome interactions in inflammatory bowel disease—Navigating towards individualised dietary strategies
por: Iris Barth, et al.
Publicado: (2024)

Novel Symptom Subgroups in Patients With Irritable Bowel Syndrome Are Associated With Healthcare Utilisation in Secondary and Tertiary Care
por: Vivek C. Goodoory, et al.
Publicado: (2026)

Analysis of Antroduodenal Motility in Patients With Hypermobility Spectrum Disorders/Hypermobile Ehlers–Danlos Syndrome
por: Kim W. E. Sweerts, et al.
Publicado: (2025)

Letter: Unlocking the Full Potential of Dietary Therapy in IBD —The Case for Universal Eating Disorder Screening
por: Luisa Bertin, et al.
Publicado: (2026)

Editorial: The Devil Is in the Detail—Interpreting the Findings of Network Meta‐Analyses
por: Christy Riggott, et al.
Publicado: (2025)

Women's Health Disorders in a Coeliac Disease Population After Diagnosis—A Nationwide Cohort Analysis
por: Rama Nanah, et al.
Publicado: (2025)

Letter: Is Enteric Neuropathy Absent in Hypermobility Spectrum Disorders/Hypermobile Ehler–Danlos Syndrome? Authors' Reply
por: Kim W. E. Sweerts, et al.
Publicado: (2025)

Editorial: Navigating the Beta‐Blocker Dilemma in Advanced Liver Cirrhosis—When Is the Right Time to Discontinue?
por: Louise J. M. Alferink, et al.
Publicado: (2024)

Editorial: Using HBcrAg and HBsAg Kinetics to Optimise Monitoring After Nucleo(s)tide Analogue Withdrawal
por: Edo J. Dongelmans, et al.
Publicado: (2026)

Impact of GLP‐1 Receptor Agonists on Alcohol‐Related Liver Disease Development and Progression in Alcohol Use Disorder
por: Chia‐Chih Kuo, et al.
Publicado: (2025)

Review Article: Surrogate Endpoints to Assess Treatment Efficacy in Disorders of Gut–Brain Interaction of Lower Gastrointestinal Tract
por: Michael Camilleri, et al.
Publicado: (2025)

Editorial: Obesity and Outcomes on Advanced Therapy in Ulcerative Colitis—The Fat of the Matter
por: Anish J. Kuriakose Kuzhiyanjal, et al.
Publicado: (2025)

Editorial: Can we predict or not predict response to hypnotherapy? That is the question. Authors' reply
por: Dipesh H. Vasant, et al.
Publicado: (2024)

Editorial: Chronic Hepatitis Delta—We Need More Screening to Improve Knowledge on the Natural History
por: J. Ventre, et al.
Publicado: (2025)

Editorial: Ulcerative Colitis Management in the Biologic Era–Data From the English Healthcare Databases. Authors' Reply
por: J. Couch, et al.
Publicado: (2025)

Prevalence and Burden of Fatigue Across Disorders of Gut–Brain Interaction: Results From the Rome Foundation Global Epidemiology Study
por: Fleur Veldman, et al.
Publicado: (2026)

Safety and Tolerability of Injectable Extended‐Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol‐Associated Liver Disease
por: Luis Antonio Díaz, et al.
Publicado: (2025)

Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows?
por: J. M. B. W. Vos, et al.
Publicado: (2025)

Letter: Safety and Tolerability of Injectable Extended Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol‐Associated Liver Disease
por: Xing Bai, et al.
Publicado: (2025)

Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows? Authors' Reply
por: Ryan M. Mathias, et al.
Publicado: (2025)

Editorial: Quantity is important!
por: Chee‐Kiat Tan
Publicado: (2024)

Editorial: TIPS in the Era of Aging and Metabolic Comorbidity—Rethinking Risks and Rewards. Authors Reply
por: Michelle Spaan, et al.
Publicado: (2026)

Editorial: Plants against animals
por: Einar S. Björnsson
Publicado: (2024)